CSL BEHRING LLC

CSL BEHRING LLC filed a Q3 report for CSL BEHRING LLC on October 20, 2025.

All filings by CSL BEHRING LLC · Everything CSL BEHRING LLC has reported

Amended

The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Oct 30, 2026.

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 20, 2025

Expenses

$330,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Pennsylvania

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Medicare/Medicaid

HR 1476--Preserving Life-saving Access to Specialty Medicines in America Act (PLASMA Act)--Medicare Part D phase-in of manufacturer liability; Issues related to Medicare Most Favored Nation

Taxation/Internal Revenue Code

Issues related to corporate tax

Trade (domestic/foreign)

Issues related to trade

Bills named in this filing 1

H.R. 1476
PLASMA Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.